Higher EZH2 expression levels correlated with younger age, smoking history and advanced TNM stage (explanation of TNM staging provided in Explanation of staging and statistical terms section) in adenocarcinomas, and importantly, rendered worse recurrence-free and overall survival independently of other known prognostic factors, such as TNM stage, tumor size and adjuvant therapy [10]. Here, EZH2 is linked to adenocarcinoma.